Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Bacteria can help skin regenerate through a process called IL-1β signaling.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

AGEs may cause hair loss by increasing inflammation in hair follicles.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

IL-1β inhibits human hair follicle growth.

Tralokinumab may help improve symptoms of atopic dermatitis and alopecia areata.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Teak leaf extract may help hair growth and reduce inflammation safely.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Treating Netherton syndrome with growth hormone and dupilumab improves growth safely.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Pumpkin Seed Oil in niosomes may help treat hair loss and improve hair growth.

Osmanthus fragrans var. aurantiacus Makino may help treat inflammation due to its antioxidative and anti-inflammatory properties.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The inhibitor DPP can promote hair growth.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.